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Over the past decades, major allergens of the most
important allergenic foods have been identified, iso-
lated, cloned and expressed as recombinant molecules.
This development has sparked off a revolution in aller-
gology towards molecular approaches for diagnosis and
therapy. The roles of individual molecules in clinical
phenotypes are being elucidated rapidly. One of the
first clear examples that individual molecules are asso-
ciated with clinical phenotypes is allergy to Rosaceae
fruits such as apple and peach. We now know that
fruit allergy caused by pollen-related PR-10 proteins
and profilins is mild and restricted to the oral cavity.
On the other hand, fruit allergy caused by lipid transfer
proteins is often at the basis of more severe systemic
reactions. Molecular diagnostics based on such obser-
vations are a promis for the future and will increasingly
replace extract-based diagnostics. Availability of recom-
binant major food allergens has also revived the inter-
est in immunotherapy for food allergy. First attempts
towards the end of the last century to treat food allergy
with aqueous extracts were upset by extremely high
incidence of side-effects. The advent of recombinant
technology now allows evaluation of safer approaches
of immunotherapy for food allergy. Recombinant food
allergens can be modified into hypo-allergenic mole-
cules that do not cause unacceptable levels of side
effects. In 2008, the European Commission decided to
fund a consortium to develop hypo-allergenic mole-
cule-based immunotherapy for the treatment of fish
and fruit allergy. The FAST project has now selected
the most promising hypo-allergenic variants of fish
parvalbumin and peach lipid transfer protein. GMP
production has started and toxicity studies and Phase I
trials are being planned. The coming years will learn
whether these approaches meet the expectations to
provide a safe and effective treatment for food allergy.
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